Toshiaki Yoshikawa

2.1k total citations
54 papers, 1.4k citations indexed

About

Toshiaki Yoshikawa is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Toshiaki Yoshikawa has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 29 papers in Oncology and 20 papers in Molecular Biology. Recurrent topics in Toshiaki Yoshikawa's work include Immunotherapy and Immune Responses (34 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Immune Cell Function and Interaction (15 papers). Toshiaki Yoshikawa is often cited by papers focused on Immunotherapy and Immune Responses (34 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Immune Cell Function and Interaction (15 papers). Toshiaki Yoshikawa collaborates with scholars based in Japan, United States and Taiwan. Toshiaki Yoshikawa's co-authors include Tetsuya Nakatsura, Itaru Endo, Daisuke Nobuoka, Yu Sawada, Shoichi Mizuno, Manami Shimomura, Toshihiro Suzuki, Yasuhiro Shimizu, Hirofumi Shirakawa and Shiro Suzuki and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Toshiaki Yoshikawa

50 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshiaki Yoshikawa Japan 21 752 676 564 224 132 54 1.4k
Yutaka Motomura Japan 14 565 0.8× 436 0.6× 516 0.9× 285 1.3× 174 1.3× 20 1.1k
Erik Bennink Netherlands 9 734 1.0× 560 0.8× 319 0.6× 143 0.6× 67 0.5× 9 1.2k
Mizue Terai United States 19 476 0.6× 453 0.7× 424 0.8× 54 0.2× 221 1.7× 41 1.3k
Helene M. Finney United Kingdom 12 815 1.1× 1.1k 1.6× 417 0.7× 111 0.5× 235 1.8× 15 1.7k
Jean‐Marc Limacher France 19 482 0.6× 767 1.1× 583 1.0× 71 0.3× 159 1.2× 44 1.4k
Fiorella Petronzelli Italy 18 391 0.5× 252 0.4× 480 0.9× 60 0.3× 179 1.4× 41 1.2k
Debattama R. Sen United States 13 1.9k 2.5× 1.4k 2.0× 574 1.0× 88 0.4× 160 1.2× 20 2.5k
Inmaculada Rodríguez Spain 19 991 1.3× 1.0k 1.5× 285 0.5× 60 0.3× 57 0.4× 24 1.5k
A C Bloem Netherlands 18 532 0.7× 363 0.5× 517 0.9× 47 0.2× 84 0.6× 34 1.4k
Liza W.J. Toonen Netherlands 12 683 0.9× 473 0.7× 192 0.3× 74 0.3× 58 0.4× 12 976

Countries citing papers authored by Toshiaki Yoshikawa

Since Specialization
Citations

This map shows the geographic impact of Toshiaki Yoshikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Yoshikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Yoshikawa more than expected).

Fields of papers citing papers by Toshiaki Yoshikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiaki Yoshikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Yoshikawa. The network helps show where Toshiaki Yoshikawa may publish in the future.

Co-authorship network of co-authors of Toshiaki Yoshikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiaki Yoshikawa. A scholar is included among the top collaborators of Toshiaki Yoshikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiaki Yoshikawa. Toshiaki Yoshikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsukawa, Tetsuya, Toshiaki Yoshikawa, Yusuke Ito, et al.. (2025). Efficient expansion of tumor-infiltrating lymphocytes from gynecologic cancer. The Journal of Immunology. 214(12). 3618–3633.
2.
Ito, Yusuke, Noriko Nakamura, Toshiaki Yoshikawa, et al.. (2025). Plasma membrane-coated nanoparticles and membrane vesicles to orchestrate multimodal antitumor immunity. Journal for ImmunoTherapy of Cancer. 13(1). e010005–e010005. 4 indexed citations
3.
4.
Hamana, Hiroshi, Eiji Kobayashi, Toshiaki Yoshikawa, et al.. (2023). Selection of highly responsive T cell receptors by an analysis combining the expression of multiple markers. Cancer Science. 114(6). 2254–2264. 1 indexed citations
5.
Ito, Yusuke, Satoshi Inoue, Haosong Zhang, et al.. (2023). Epigenetic profiles guide improved CRISPR/Cas9-mediated gene knockout in human T cells. Nucleic Acids Research. 52(1). 141–153. 12 indexed citations
6.
Suzuki, Jun, Toshiaki Yoshikawa, Tetsuya Nakatsura, et al.. (2020). Tumor-Infiltrating T Cells Concurrently Overexpress CD200R with Immune Checkpoints PD-1, CTLA-4, and TIM-3 in Non-Small-Cell Lung Cancer. Pathobiology. 88(3). 218–227. 7 indexed citations
7.
Yoshikawa, Toshiaki, Yu Sawada, Manami Shimomura, et al.. (2016). Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model. Biochemistry and Biophysics Reports. 5. 482–491. 13 indexed citations
8.
Uchida, Tetsuya, Yu Sawada, Nobuhiro Tsuchiya, et al.. (2015). Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice. Biochemical and Biophysical Research Communications. 469(1). 138–143. 17 indexed citations
9.
Tomita, Yusuke, Akira Yuno, Masatoshi Hirayama, et al.. (2015). Identification of glypican-3-derived long peptides activating both CD8+and CD4+T cells; prolonged overall survival in cancer patients with Th cell response. OncoImmunology. 5(1). e1062209–e1062209. 30 indexed citations
10.
Yoshikawa, Toshiaki, et al.. (2014). Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy. International Journal of Oncology. 45(5). 1847–1856. 9 indexed citations
11.
Ofuji, Kazuya, Toshiaki Yoshikawa, Manami Shimomura, et al.. (2014). A peptide antigen derived from EGFR T790M is immunogenic in non-small cell lung cancer. International Journal of Oncology. 46(2). 497–504. 16 indexed citations
12.
Sawada, Yu, et al.. (2014). Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes. International Journal of Oncology. 46(1). 28–36. 67 indexed citations
13.
Yoshikawa, Toshiaki, et al.. (2013). Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide. International Journal of Oncology. 42(3). 831–838. 14 indexed citations
14.
Sawada, Yu, Toshiaki Yoshikawa, Daisuke Nobuoka, et al.. (2012). Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival. Clinical Cancer Research. 18(13). 3686–3696. 251 indexed citations
15.
Nobuoka, Daisuke, Toshiaki Yoshikawa, Mari Takahashi, et al.. (2012). Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy. Cancer Immunology Immunotherapy. 62(4). 639–652. 39 indexed citations
16.
Yoshikawa, Toshiaki, Munehide Nakatsugawa, Shiro Suzuki, et al.. (2011). HLA‐A2‐restricted glypican‐3 peptide‐specific CTL clones induced by peptide vaccine show high avidity and antigen‐specific killing activity against tumor cells. Cancer Science. 102(5). 918–925. 66 indexed citations
17.
Suzuki, Shiro, Toshiaki Yoshikawa, Kiyosumi Shibata, et al.. (2011). Glypican‐3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma. Cancer Science. 102(9). 1622–1629. 20 indexed citations
18.
Kayamuro, Hiroyuki, Yasuhiro Abe, Yujiro Yoshioka, et al.. (2010). Mutant TNF-alpha, mTNF-K90R, is a novel candidate adjuvant for a mucosal vaccine against HIV.. PubMed. 65(4). 254–6. 5 indexed citations
19.
Yoshikawa, Toshiaki, et al.. (2008). Measurement of Required Power with Human-Powered Aircraft in Take-off Ground Running. JOURNAL OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES. 56(655). 391–395.
20.
Yoshikawa, Toshiaki, et al.. (1992). Influence of recrystallization on the outgassing characteristics of copper. Journal of Vacuum Science & Technology A Vacuum Surfaces and Films. 10(6). 3465–3471. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yutaka Motomura Breakdown of academic impact, for papers by Erik Bennink Breakdown of academic impact, for papers by Mizue Terai Breakdown of academic impact, for papers by Helene M. Finney Breakdown of academic impact, for papers by Jean‐Marc Limacher Breakdown of academic impact, for papers by Fiorella Petronzelli Breakdown of academic impact, for papers by Debattama R. Sen Breakdown of academic impact, for papers by Inmaculada Rodríguez Breakdown of academic impact, for papers by A C Bloem Breakdown of academic impact, for papers by Liza W.J. Toonen
Rankless by CCL
2026